A brief overview of various vaccines against nCOVID19, including safety, efficacy, reported cases, clinical trials, and progress

Sumel Ashique; Shubneesh Kumar; Himanshu Kumar; Jayita Roy; Soumen Pal; Swagata Pal

doi:10.4103/kleuhsj.kleuhsj_505_22

Users Online: 1

Cover page of the Journal of Health Sciences

REVIEW ARTICLE

Year : 2023 | Volume : 16 | Issue : 1 | Page : 13-29

A brief overview of various vaccines against nCOVID19, including safety, efficacy, reported cases, clinical trials, and progress

Sumel Ashique¹, Shubneesh Kumar¹, Himanshu Kumar¹, Jayita Roy², Soumen Pal³, Swagata Pal⁴
¹ Department of Pharmaceutics, Bharat Institute of Technology, School of Pharmacy, Meerut, Uttar Pradesh, India
² Department of Pharmaceutics, Radha Govind University, Radha Govind Nagar, Lalki Ghati, Jharkhand, Ramgarh, India
³ Department of Pharmacy, Meerut Institute of Technology (MIT), NH 58, Baral Partapur, Meerut, Uttar Pradesh, India
⁴ Department of Pharmaceutics, Bengal College of Pharmaceutical Sciences and Research, BASU, Gandhar Sarani, Bidhannagar, Durgapur, West Bengal, India

Correspondence Address:
Asst. Prof. Sumel Ashique
Department of Pharmaceutics, Bharat Institute of Technology, School of Pharmacy, Meerut - 250 103, Uttar Pradesh
India

Source of Support: None, Conflict of Interest: None

Check

DOI: 10.4103/kleuhsj.kleuhsj_505_22

Even if many countries are against it since vaccinations are not readily available, industrialized countries continue to make some vaccines designated under the World Health Organization's emergency use listing mandatory for entry into their countries. The first half of 2021 has seen the introduction of SARS-CoV-2 vaccinations in several countries, after the exceptional speed of vaccine development and testing in 2020. Using keywords in online databases such as Pubmed, Scopus, Web of Science, Cochrane, and Embase, this systematic search was carried out. The findings were collected into a report. We were unable to do an adequate human study because we included so many different kinds of vaccinations. A look at current vaccination-controlled trials and actual facts on immunization success is also presented. The efficacy of new vaccines is continually being tested in ongoing vaccine trials. Increasing the alternatives for global vaccine production to manufacture sufficient vaccine shots for international usage and to enhance the statistics for the potential utility of various vaccination platforms in forthcoming pandemics are also a result of this.

[FULL TEXT] [PDF]*

Table of Contents

Similar in PUBMED

Search Pubmed for

Search in Google Scholar for

Related articles

Citation Manager

Access Statistics

Reader Comments

Email Alert *

Add to My List *

* Requires registration (Free)

Article Access Statistics

Viewed	380

Printed	6

Emailed	0

PDF Downloaded	46

Comments	[Add]